Advanced Refractive predicts first-quarter 2007 launch for novel cataract emulsifier:
This article was originally published in Clinica
Advanced Refractive Technologies believes it could be set to file later this year a US marketing application for its next-generation cataract emulsifier. Its Accupulse device is novel in that it combines water-jet and ultrasound technologies, the company claims. Accupulse is to undergo animal studies designed to optimise the final design characteristics of the product and to prepare the device for FDA 510(k) approval. A 510(k) filing could be completed in the fourth quarter of 2006, with approval and initial sales occurring during the first quarter 2007, said Randy Bailey, the San Clemente, California firm's president and CEO. Around 18 million cataract surgeries are forecast for 2007, the company added.